UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of experimentally-induced diabetes on rat hippocampus and the potential neuroprotective effect of Cerebrolysin combined with insulin. A histological and immunohistochemical study

Egyptian Journal of Basic and Applied Sciences, 2023-12, Vol.10 (1), p.255-273

2023

Volltextzugriff (PDF)

Cerebrolysin administration counteracts elevated oxidative stress in blood of patients with Parkinson’s disease

Fiziolohichnyĭ zhurnal, 2022-08, Vol.68 (4), p.20-27

2022

Volltextzugriff (PDF)

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

Medicinal research reviews, 2021-09, Vol.41 (5), p.2775-2803

2021

Volltextzugriff (PDF)

Acute Combined Cerebrolysin and Nicotinamide Administration Promote Cognitive Recovery Through Neuronal Changes in the Hippocampus of Rats with Permanent Middle Cerebral Artery Occlusion

Neuroscience, 2024-06, Vol.549, p.76-83

2024

Volltextzugriff (PDF)

The administration of Cerebrolysin elicits neuroprotective and neurorepair effects in an animal model of type 1 diabetes mellitus

Behavioural brain research, 2024-08, Vol.471, p.115115, Article 115115

2024

Volltextzugriff (PDF)

Environmental enrichment and cerebrolysin improve motor and cognitive performance in a rat model of stroke, in conjunction with an increase in hippocampal AMPA but not NMDA receptor subunits

Brain research, 2024-02, Vol.1825, p.148694-148694, Article 148694

2024

Volltextzugriff (PDF)

Cerebrolysin prevents sleep deprivation induced memory impairment and oxidative stress

Physiology & behavior, 2020-04, Vol.217, p.112823-112823, Article 112823

2020

Volltextzugriff (PDF)

Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches

Frontiers in cellular neuroscience, 2014-04, Vol.8, p.112-112

2014

Volltextzugriff (PDF)

Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats

Brain research bulletin, 2018-06, Vol.140, p.197-204

2018

Volltextzugriff (PDF)

Nature's Toolbox for Alzheimer's Disease: A Review on the Potential of Natural Products as Alzheimer's Disease Drugs

Neurochemistry international, 2024-06, Vol.176, p.105738, Article 105738

2024

Volltextzugriff (PDF)

Therapeutic effect of Cerebrolysin on reducing impaired cerebral endothelial cell permeability

Neuroreport, 2021-03, Vol.32 (5), p.359-366

2021

Volltextzugriff (PDF)

Using of cerebrolysin in patients with epilepsy

Russkiĭ zhurnal detskoĭ nevrologii, 2018-04, Vol.13 (1), p.34-41

Kotov, A. S.

2018

Volltextzugriff (PDF)

Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis

Exploration of Neuroprotective Therapy, 2023-10, Vol.3 (5), p.398-408

2023

Volltextzugriff (PDF)

Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the International Council of Experts (May 12, 2023)

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Vol.123 (9), p.121

2023

Volltextzugriff (PDF)

Neuroprotective therapy in acute ischemic stroke

Nevrologii͡a︡, neĭropsikhiatrii͡a︡, psikhosomatika, 2021-08, Vol.13 (4), p.94-102

Kulesh, A. A.

2021

Volltextzugriff (PDF)

Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury: Laboratory investigation

Journal of neurosurgery, 2013-06, Vol.118 (6), p.1343-1355

2013

Volltextzugriff (PDF)

Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment

Medicine (Baltimore), 2024-03, Vol.103 (13), p.e37593

2024

Volltextzugriff (PDF)

Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression

Journal of psychiatric research, 2024-04, Vol.172, p.171-180

2024

Volltextzugriff (PDF)

Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer’s disease: the role of the ApoE genotype

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2020, Vol.120 (10), p.31

2020

Volltextzugriff (PDF)

Optimized approach for active peptides identification in Cerebrolysin by nanoLC-MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2023-06, Vol.1225, p.123755-123755, Article 123755

2023

Volltextzugriff (PDF)

Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin

Medicinal research reviews, 2023-09, Vol.43 (5), p.1668-1700

2023

Volltextzugriff (PDF)

Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin

Psychiatry research, 2018-12, Vol.270, p.430-437

2018

Volltextzugriff (PDF)

Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway

Frontiers in pharmacology, 2019-10, Vol.10, p.1245-1245

2019

Volltextzugriff (PDF)

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial

Stroke (1970), 2016-01, Vol.47 (1), p.151-159

2016

Volltextzugriff (PDF)

Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam

CNS & neurological disorders drug targets, 2022-08, Vol.21 (7), p.621-630

2022

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Englisch
(306)
Russisch
(26)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Cerebrolysin
(318)
Science & Technology
(249)
Life Sciences & Biomedicine
(243)
Neurosciences & Neurology
(166)
Neurosciences
(124)
Male
(105)
Animals
(101)
Clinical Neurology
(84)
Humans
(84)
Amino Acids - Pharmacology
(71)
Amino Acids - Therapeutic Use
(69)
Rats
(61)
Female
(57)
Neuroprotective Agents - Therapeutic Use
(54)
Neuroprotection
(47)
Alzheimer's Disease
(43)
Neurology
(42)
Treatment Outcome
(42)
Neuroprotective Agents - Pharmacology
(41)
Traumatic Brain Injury
(41)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of experimentally-induced diabetes on rat hippocampus and the potential neuroprotective effect of Cerebrolysin combined with insulin. A histological and immunohistochemical study

Cerebrolysin administration counteracts elevated oxidative stress in blood of patients with Parkinson’s disease

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

Acute Combined Cerebrolysin and Nicotinamide Administration Promote Cognitive Recovery Through Neuronal Changes in the Hippocampus of Rats with Permanent Middle Cerebral Artery Occlusion

The administration of Cerebrolysin elicits neuroprotective and neurorepair effects in an animal model of type 1 diabetes mellitus

Environmental enrichment and cerebrolysin improve motor and cognitive performance in a rat model of stroke, in conjunction with an increase in hippocampal AMPA but not NMDA receptor subunits

Cerebrolysin prevents sleep deprivation induced memory impairment and oxidative stress

Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches

Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats

Nature's Toolbox for Alzheimer's Disease: A Review on the Potential of Natural Products as Alzheimer's Disease Drugs

Therapeutic effect of Cerebrolysin on reducing impaired cerebral endothelial cell permeability

Using of cerebrolysin in patients with epilepsy

Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis

Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the International Council of Experts (May 12, 2023)

Neuroprotective therapy in acute ischemic stroke

Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury: Laboratory investigation

Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment

Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression

Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer’s disease: the role of the ApoE genotype

Optimized approach for active peptides identification in Cerebrolysin by nanoLC-MS

Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin

Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin

Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial

Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam

Suchergebnisse filtern